Max Planck Society for the Advancement of Science EV donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 5 252,895 794,572 100,000 100,000 100,000 100,000 100,000 252,895 252,895 1,509,813 1,509,813 2,010,151 2,010,151
Global health 5 252,895 794,572 100,000 100,000 100,000 100,000 100,000 252,895 252,895 1,509,813 1,509,813 2,010,151 2,010,151

Donation amounts by donor and year for donee Max Planck Society for the Advancement of Science EV

Donor Total 2015 2012 2009 2008
Bill and Melinda Gates Foundation (filter this donee) 3,972,859.00 252,895.00 1,509,813.00 2,110,151.00 100,000.00
Total 3,972,859.00 252,895.00 1,509,813.00 2,110,151.00 100,000.00

Full list of documents in reverse chronological order (0 documents)

There are no documents associated with this donee.

Full list of donations in reverse chronological order (5 donations)

Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations

Graph of donations and their timeframes
DonorAmount (current USD)Amount rank (out of 5)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation252,895.0032015-09-28Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define a biosignature for increased risk of developing TB to: (i) accelerate clinical vaccine trials, (ii) facilitate design of preventive drug therapy and (iii) provide guidelines for improved diagnosis.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,509,813.0022012-11-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define a biosignature for increased risk of developing TB to: (i) accelerate clinical vaccine trials, (ii) facilitate design of preventive drug therapy and (iii) provide guidelines for improved diagnosis.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,010,151.0012009-11-16Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify molecular and immune responses of pathogens and patients which correlate with protection from TB; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation100,000.0042009-09-29Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to develop a broad-range vaccine, using your knowledge of bioinformatics, biochemistry, and immunology in an interdisciplinary approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.0042008-09-10Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to identify and classify all the molecules that make up the cell wall of gram-negative bacteria, which causes infectious diseases. By recognizing common elements among molecules, a broad-range vaccine could be developed to protect these diseases.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.